Vedolizumab-Induced Liver Injury

Abstract: Drug-induced liver injury is an important cause of acute liver injury. Immunomodulatory therapies, such as vedolizumab (VDZ), are being increasingly used for the treatment of several diseases, most importantly inflammatory bowel disease. Several studies have demonstrated the safety of this...

Full description

Bibliographic Details
Main Author: Saraiva,Miguel Mascarenhas (author)
Other Authors: Ribeiro,Tiago (author), Dias,Emanuel (author), Lopes,Joanne Lopes (author), Cardoso,Hélder (author), Macedo,Guilherme (author)
Format: report
Language:eng
Published: 2021
Subjects:
Vedolizumab
Acute liver injury
Hepatotoxicity
Drug-induced liver injury
Inflammatory bowel disease
Online Access:http://scielo.pt/scielo.php?script=sci_arttext&pid=S2341-45452021000600410
Country:Portugal
Oai:oai:scielo:S2341-45452021000600410

Internet

http://scielo.pt/scielo.php?script=sci_arttext&pid=S2341-45452021000600410

Similar Items